Disability Community and Identity: Perceptions of Prenatal Screening
By Deborah Kaplan and Marsha Saxton,
Excerpt from Our Bodies Ourselves (2005 edition)
| 11. 30. 2004
People with disabilities come to the genetic screening debate from a perspective that perplexes many scientists and medical professionals. We are purportedly the ones helped by genetic advances, yet we are critical of much of the research. Those with disabilities who have lived their lives creatively managing the logistics of a disability, as well as fighting disability discrimination, may regard the new genetic "options" as a way to promote selective abortion. In an attempt to "eliminate disability," medical science may harbor motivations that spur the prenatal technologies in the direction of eliminating disabled people before they are born rather than addressing fundamental social causes of disability discrimination and the resulting lowered socio-economic status of citizens with disabilities.
This article explores the social origins of disability discrimination and its implications for prenatal diagnosis, and examines some of the objections to screening expressed by people with disabilities.
Definitions of Disability
Disability policy scholars describe four different historical and social models of disability: (1) A moral model of disability which regards disability as the result of sin; (2) A medical model of disability...
Related Articles
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Kiana Jackson and Shannon Stubblefield, New Disabled South | 02.09.2026
"MC0_8230" via Wikimedia Commons licensed under CC by 2.0
This report documents a deliberate assault on disabled people in the United States. Not an accident. Not a series of bureaucratic missteps. An assault that has been coordinated across agencies...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...